Cevostamab (without CD3) Biosimilar - Anti-FCRL5 Antibody - BSA and Azide free (A318873)

Cevostamab (without CD3) Biosimilar - Anti-FCRL5 Antibody - BSA and Azide free

Recombinant humanized monoclonal antibody to FCRL5.

ELISA, Flow Cytometry

ELISA: 1:5,000-10,000, Flow Cytometry: 1:100

Human

Humanized

Monoclonal

IgG1

Affinity chromatography.

Lyophilized

Reconstitute with distilled sterile water.

Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.

BXMAS1, CD307e, Fc receptor homolog 5, Fc receptor-like protein 5, FcR-like protein 5, FCRH5, Immune receptor translocation-associated protein 2, IRTA2